Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Inventiva (France) | Researchclopedia

Back to institutions

Inventiva (France)

Daixcompany

62

Works

13,522

Citations

64

h-index

Top Research Topics

Liver Disease Diagnosis and Treatment Peroxisome Proliferator-Activated Receptors Pulmonary Hypertension Research and Treatments

Top Researchers

Marco Matucci‐Cerinic University of Geneva

1,230 works50,576 citationsh-index: 100

Recent Research

P13.15.B STRONG EVIDENCES TO TARGET YAP1/TAZ-TEAD IN MENINGIOMA: PRECLINICAL STUDY.

Grégoire Mondielli,Séverine Delaporte,et al.

20250 citations

Pancreatitis Pathology and Treatment

Lysosomal Storage Disorders Research

Hippo pathway signaling and YAP/TAZ

Diet, Metabolism, and Disease

Epigenetics and DNA Methylation

Liver Disease and Transplantation

Systemic Sclerosis and Related Diseases

Metabolism, Diabetes, and Cancer

Carbohydrate Chemistry and Synthesis

Prisca Honoré AbbVie (United States)

170 works12,156 citationsh-index: 56

Lois K. Lee Boston Children's Hospital

284 works8,785 citationsh-index: 43

Claude Robert The Quebec Population Health Research Network

188 works5,282 citationsh-index: 40

Jean‐Louis Junien Inventiva (France)

102 works4,301 citationsh-index: 38

Michael E. Kort AbbVie (United States)

98 works3,354 citationsh-index: 30

Insect Meal Mixture as Sustainable Fishmeal Substitute in Rainbow Trout (Oncorhynchus mykiss) Diets

H. Abdallah,Sara Bellezza Oddon,et al.

20250 citations

Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD

François Briand,Caroline Dubroca,et al.

20252 citations

Biomarkers of Histological Response in Lanifibranor-treated Patients With Metabolic Dysfunction-associated Steatohepatitis

Jérôme Boursier,Hugo Hervé,et al.

20252 citations

Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment

Pierre‐Emmanuel Rautou,Shivani Chotkoe,et al.

20254 citations

Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD

Diana Barb,Srilaxmi Kalavalapalli,et al.

202555 citations